TLX

Telix Pharmaceuticals Limited

HealthcareBiotechnologyAUUSDPeers →Country macro →

$10.09

LiveJun 18, 2026

Market cap

$3.42B

52w range

6.28 – 16.98

P / E

—

EPS

—

Volume

90.46K

Revenue · FY

—

Explain this page

Arphra AIPlain-English read on Telix Pharmaceuticals Limited’s valuation

Enterprise value

$5.4B

Market cap

$4.91B

Net debt

—

Total debt

—

Cash & ST inv.

—

Capital structure

· balance sheet · 2026-06-20

Market capitalisation$4.91B

+ Total debt+—

− Cash & short-term investments−—

= Enterprise value$5.4B

Valuation

· key metrics · TTM

EV / EBITDA145.6×

EV / Sales4.4×

EV / FCF-69.5×

Net debt / EBITDA13.1×

Debt / Equity—

Arphra AIPlain-English read on the EV build & leverage